Skip to main content

Table 1 Oligonucleotides used for NBN PCR amplification and sequencing.

From: Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2French Canadian families with high risk of breast cancer

 

F/R1

Oligonucleotide sequence (5'→3')

Annealing temp. (°C)

PCR lenght (bp)

MgCl2 final conc. (mM)

Comments

Genomic sequence

Exon 1

F

GACGTTAAGACAAGTTGATTTGAACTTAGA*

60

965/

0.5

2% DMSO added to the PCR reaction

 

R

TCCGCCCATGCTAACTTCCT

 

1113

  
 

F2

TTTAGTAGTGCGCAGGATGTAGAC

    

Exon 2

F

CCTTTGATAGCCTTCAGTGAGGC

64

743

1.0

Sequencing primer:

 

R

AGCCAGAGTCATGAAGGTCTGTTC

   

CCACTGGTACCACTGCCACA

Exon 3

F

GTCAGGAGAATCCCCACTGACTT*

60

548

1.5

 
 

R

GGCACAGAGTCCAATACTGTGCT

    

Exon 4

F

TGGGAAGTTACATTTCTTCGATTCC*

58

728

1.5

 
 

R

GCACTGTCATAACCTTCTCGGTG

    

Exon 5

F

GCAGTGACCAAAGACCGACTTCTA*

58

561

1.5

 
 

R

TGAGGTTACCTCAGTGCCATTTACT*

    

Exon 6

F

AAACGCGATTAGATGCTTTTTGTC*

60

630

1.5

 
 

R

ACCCCACTTTGGTACACAGAAC

    

Exon 7

F

CCACAGAGAGTGTAACAGTTCCAGG*

63

1100

1.0

2% DMSO added to the PCR reaction

 

R

TTAATTCTTGTATCGGCCGGG

    

Exon 8

F

TAACAGTGCCCCAGCGAGTAAG*

58

785

1.5

 
 

R

TCCTCTTACACTGTCGACCCTTAGA

    

Exon 9

F

TTAGATAAGCCCGTCATAGATGCC*

58

516

1.5

 
 

R

TAACTACTCGCCGCTCCTTTACA

    

Exon 10

F

GTTTGTCAGTCGTCTATAGTGGAGCA*

58

763

1.5

 
 

R

AATTGCGGCAAGTAAAATAACACG

    

Exon 11

F

CCCTGCCCACAACCTTACTACG*

60

1500

1.5

 
 

R

GACCACAGCCATGAATGAGTGG *

    

Exon 12

F

TCCTACCATCTACAGACAACCATGG

58

619

1.5

 
 

R

CCATGATCAATCCATTTCAAGGC *

    

Exon 13

F

GCAAACAGTGCTGAGATTTTGTGTC

58

850

1.5

 
 

R

CCTGAGCTAAAGAACCTCCTCAAGTAG *

    

Exon 14

F

CAACATCTCCTGCTTGGACTCTG

60

638

1.0

Sequencing primer:

 

R

GAAGAATTTGCTTGAAGGCCACC

   

GATGGGTTTAGAACAGAGTTACTGCT

Exon 15

F

GAACTCAGATGTGGTGACCTCCAG

58

441

1.5

 
 

R

CAATTTCACACAATTCGGGAACC *

    

Exon 16

F

GAGGAATGGGGATCTTTGAAGC

58

457

1.5

Sequencing primer:

 

R

GTAACTTAAATCGCTTCTATACAC

   

AAGCAACATCAAAGGGATACATGA

cDNA

PCR 1

F

GTTACGCGGTTGCACGTCG

64

998

1.5

Exons 1 to 8

 

R

GTCATGAAAATCACCGCCAATC

    

PCR 2

F

TCTTTTTGGCTCCGGGAACG

62

567

1.5

Exons 7 to 10

 

R

GCTGCTGCTGAGAAGCCCTATC

   

Overlap of 169 pb with PCR1

PCR 3

F

CCCACTGTAAAGGAGTCCTGCA

62

634

1.5

Exons 10 to 12

 

R

TACTTTCTGGTACTGCTTCATCACT

   

Overlap of 151 pb with PCR2

PCR 4

F

CCATAGAAGATGAAGTATTGGA

62

700

1.5

Exons 11 to 16

 

R

GTAACTTAAATCGCTTCTATACAC

   

Overlap of 165 pb with PCR3

Promoter cloning

 

F

GACGACGCTAGCGACGTTAAGACAAGTTGATTTGAACTTAGA

62

515

1.0

2% DMSO added to the PCR reaction

Added restriction sites are underlined

 

R

GACGACAAGCTTATCGGTCCGGCTCCTCAGGGCTG

    
  1. 1 Primer direction: forward (F) or reverse (R) 2 Alternative primer Oligonucleotides used as sequencing primers are marked with an (*)